United States Influenza Vaccines Market: Focus on Persons Vaccinated, Pricing, Production, Supply, Promising Influenza Vaccines, Clinical Trials, Regulatory, Reimbursement, Distribution Channel, Major Deals, Key Players, Recent Developments – Size, Share, Trends, Analysis, Demand, Opportunity, and Forecast, 2022 – 2030
Report Code: KNJ1198818
Publisher: Date of Publish:
No. of Pages: 220 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
The United States Influenza Vaccines market size is expected to reach USD 7,007 million by 2030. It is expected to expand at a CAGR of 6.9% from 2021 to 2030. This new market report offerings an wide-ranging study of the entire United States influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The report also provides up-to-date market size data for the period 2015 - 2021 and an illustrative forecast to 2030 covering key market aspects like market value and volume for influenza vaccines. This Newest and Comprehensive United States Influenza Vaccines Market Research Report 2022 Delivers: The United States Influenza Vaccines Market Size, Insights, Analysis and Forecast,2015-2030 The United States Number of Persons Vaccinated with Influenza Vaccines and Forecast, 2015 - 2030 Analyzes the United States Children Being Vaccinated with Influenza Vaccines and Forecast,2015 - 2030 Analyzes the United States Adults Being Vaccinated with Influenza Vaccines and Forecast, 2015 - 2030 Key Market Growth Drivers and Challenges of the United States Influenza Vaccines Market The United States Influenza Vaccines Pricing Analysis, Trends and Insights The United States Influenza Vaccines Production, Supply, and Allocation (By Companies) The United States Influenza Vaccines Distribution and Demand Analysis (2010 - 2021) Examines the Effectiveness of the Influenza Vaccines in the United States (2004 – 2021) Thoroughly Evaluates Rapid Diagnostic Testing for the Management of Influenza Distribution Channel and Technique Detailed Insights of Influenza Vaccination in the United States Reimbursement Environment of the United States Influenza Vaccines Market Regulatory Framework of the United States Influenza Vaccines Market Major Deals and Agreement Activities in the Influenza Vaccines Market An Insightful Analysis of the Promising Influenza Vaccines in the Clinical Development Analyses the Most Recent Clinical Trials of the Influenza Vaccines between 2020 and 2021 A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Influenza Vaccines Market Value, and Recent Development An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development The Major and Emergent Market Players for the U.S Influenza Vaccines Market are Listed Below : Sanofi Pasteur GlaxoSmithKline (GSK) Seqirus (CSL Limited) AstraZeneca Novavax BiondVax Pharmaceuticals Ltd. Medicago Moderna Inc Pneumagen Daiichi–Sankyo Altimmune FluGen Imutex Versatope Therapeutics, Inc EpiVax, Inc Key Questions Answered by this Latest 2022 Report: • What is the current scenario of the U.S. influenza vaccines market? • What is the total market size and forecast (until 2030) for the U.S. influenza vaccines market? • How many persons being vaccinated with influenza vaccines in the US during 2015 – 2027? • How effective is influenza(flu) shot for 2021? • What percentage of the United States do people get the flu vaccine? • What are the key marketed influenza vaccines available in the United States? • What are the major drivers of the United States influenza vaccines market? • What are the major inhibitors of the United States influenza vaccines market? • What is the reimbursement pattern in the United States influenza vaccines market? • What is the regulatory framework in the United States influenza vaccines market? • What are the major deals and agreement happenings in the United States influenza vaccines market? • What are the upcoming influenza vaccines that will have a significant impact on the market in the future? • Who are the top market players? What are their happenings, vaccine revenue, current developments, and scenarios? • Who are the emerging players? What are their happenings, clinical development, platform technology, phase, and current developments? • How is the market predicted to develop in the future?
1. Executive Summary 2. United States Influenza Vaccines Market Size, Insights, Analysis and Forecasts (2015 - 2030) 3. United States Number of Persons Vaccinated with Influenza Vaccines (2015 - 2030) 3.1 Number of Children Vaccinated with Influenza Vaccines 3.2 Number of Adults Vaccinated with Influenza Vaccines 4. Key Market Growth Drivers and Challenges of the United States Influenza Vaccines Market 4.1 Market Drivers 4.2 Market Challenges 5. United States Influenza Vaccines Pricing Analysis, Trends and Insights 6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies) 7. United States Influenza Vaccines Distribution and Demand Analysis (2010 - 2021) 8. Effectiveness of Influenza Vaccines in the United States (2004 – 2021) 9. Rapid Diagnostic Testing for the Management of Influenza 10. Distribution Channel and Technique Detailed Insights of Influenza Vaccination in the United States 11. Reimbursement Environment of the United States Influenza Vaccines Market 12. Regulatory Framework of the United States Influenza Vaccines Market 13. Major Deals and Agreement Activities in the Influenza Vaccines Market 13.1 Merger and Acquisitions 13.2 Collaboration Deals 13.3 Licensing Agreement 13.4 Exclusive Agreement 13.5 Distribution Agreement 14. Promising Influenza Vaccines in the Clinical Development 15. Influenza Vaccines Clinical Trial Insights by Phase, Company and Country 15.1 Year 2021 15.2 Year 2020 16. Key Players Analysis 16.1 Sanofi Pasteur 16.1.1 Business Overview 16.1.2 Influenza Vaccines Portfolio 16.1.3 Influenza Vaccines Sales Value Analysis 16.1.4 Promising Influenza Vaccines in the Clinical Development 16.1.5 Recent Development 16.2 GlaxoSmithKline (GSK) 16.2.1 Business Overview 16.2.2 Influenza Vaccines Portfolio 16.2.3 Influenza Vaccines Sales Value Analysis 16.2.4 Recent Development 16.3 Seqirus 16.3.1 Business Overview 16.3.2 Influenza Vaccines Portfolios 16.3.3 Influenza Vaccines Sales Value Analysis 16.3.4 Promising Influenza Vaccines in the Clinical Development 16.3.5 Recent Development 16.4 AstraZeneca 16.4.1 Business Overview 16.4.2 Influenza Vaccines Portfolio 16.4.3 Influenza Vaccines Sales Value Analysis 16.4.4 Recent Development 17. Emerging Players Analysis 17.1 Novavax 17.1.1 Business Overview 17.1.2 Promising Influenza Vaccines in the Clinical Development 17.1.3 Recent Development 17.2 BiondVax Pharmaceuticals Ltd. 17.2.1 Business Overview 17.2.2 Promising Influenza Vaccines in the Clinical Development 17.2.3 Recent Development 17.3 Medicago 17.3.1 Business Overview 17.3.2 Promising Influenza Vaccines in the Clinical Development 17.3.3 Recent Development 17.4 Moderna Inc 17.4.1 Business Overview 17.4.2 Promising Influenza Vaccines in the Clinical Development 17.4.3 Recent Development 17.5 Pneumagen 17.5.1 Business Overview 17.5.2 Promising Influenza Vaccines in the Clinical Development 17.5.3 Recent Development 17.6 Altimmune 17.6.1 Business Overview 17.6.2 Promising Influenza Vaccines in the Clinical Development 17.6.3 Recent Development 17.7 Daiichi Sankyo 17.7.1 Business Overview 17.7.2 Promising Influenza Vaccines in the Clinical Development 17.7.3 Recent Development 17.8 FluGen 17.8.1 Business Overview 17.8.2 Promising Influenza Vaccines in the Clinical Development 17.8.3 Recent Development 17.9 Imutex 17.9.1 Business Overview 17.9.2 Promising Vaccines in the Clinical Development 17.9.3 Recent Development 17.10 EpiVax 17.10.1 Business Overview 17.10.2 Promising Influenza Vaccines in the Clinical Development 17.10.3 Recent Development 17.11 Versatope Therapeutics, Inc. 17.11.1 Business Overview 17.11.2 Promising Influenza Vaccines in the Clinical Development 17.11.3 Recent Development
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com